Key points
- The White House launched TrumpRx.gov, a federal portal listing discounted prices and coupons for 43 brand-name medicines, including GLP-1s such as Zepbound and Ozempic.
- TrumpRx does not sell drugs directly — it links users to manufacturer or pharmacy pages and offers printable coupons and price comparisons.
- Early partners and pricing claims rely on “most-favored-nation” deals negotiated with about 16 major drugmakers; critics warn many insured patients may see little change to copays or deductibles.
- The site could lower out-of-pocket cash prices for the uninsured or those paying cash, but legal, insurance and pharmacy-network nuances mean savings vary widely.
Quick overview — what TrumpRx.gov is and how it works
TrumpRx.gov is a White House-backed listing and coupon portal that displays “most-favored-nation” prices for select branded medicines.
Users can search the site for a drug, compare the advertised cash price and click through to buy on a manufacturer page or claim a coupon at a participating pharmacy.
What’s on the list — notable drugs (Zepbound, Ozempic and more)
At launch the site lists about 43 medicines, including GLP-1 weight-loss and diabetes drugs such as Zepbound, Ozempic and Wegovy-class products.
Officials say prices for some GLP-1s were cut to roughly $150–$350 per month under the administered price agreements.
The GoodRx connection and how coupons play in
TrumpRx directs some users to coupons and manufacturer direct-to-consumer pages; companies such as GoodRx were mentioned as a distribution or comparison partner at rollout.
That structure makes TrumpRx more a curated shopping and coupon hub than a government-run pharmacy or subsidy program.
Who is most likely to save — and who might not
Cash-paying patients, the uninsured, and those whose insurance copays exceed the TrumpRx cash price could see real savings.
Insured patients should check plan rules: purchases via TrumpRx coupons often do not count toward insurance deductibles or out-of-pocket maximums, so insurance holders may not always benefit.
The policy pitch and the political angle
The White House framed TrumpRx as delivering “world-lowest” prices by pushing for parity with prices paid overseas and negotiating “most-favored-nation” arrangements.
Critics say the initiative can look like a new retail channel for drugmakers that bypasses insurers and PBMs rather than a structural fix to U.S. drug pricing.
Red flags and expert cautions to keep in mind
Health-policy analysts caution that advertised savings can be illusory for many because of insurance design, prior-authorization rules, and pharmacy network constraints.
Legal and implementation details — which drugs qualify, how long prices stay fixed, and whether more generics join the list — will determine long-term impact.
How to use TrumpRx.gov safely (step-by-step)
- Search the site for your exact drug and dose and note the listed cash price.
- Before buying, compare your insurer’s copay and whether the coupon purchase counts toward your deductible.
- If you pay cash, bring the coupon or follow the manufacturer link; keep receipts in case you later need to reconcile with insurance or taxes.
Quick FAQ — short answers readers want
Is TrumpRx a pharmacy?
No—TrumpRx is a federal portal that lists prices and coupons and directs users to pharmacies or manufacturer pages; it does not dispense medications.
Is Zepbound on TrumpRx and how much will it cost?
Zepbound is listed among GLP-1s the administration highlighted; the White House said such GLP-1s could be priced roughly $150–$350/month under their deals. Exact prices vary by dose and program.
Will purchases count toward my insurance deductible?
Often not — many coupons and manufacturer direct purchases don’t apply toward insurer deductibles or out-of-pocket limits. Check with your plan before buying.
Will you try TrumpRx.gov to buy a prescription drug?
Final take — practical, not political
TrumpRx.gov could deliver real cash savings for some patients—particularly the uninsured and cash-paying consumers on expensive branded drugs.
But for many insured Americans the effects will be muted unless the program’s scope broadens, pharmacies and payers adapt, and the complex legal and rebate architecture around drug pricing changes in durable ways.
Disclaimer: This article summarizes contemporaneous reporting and the TrumpRx.gov fact sheet as of February 2026. It is informational—not medical or legal advice. Check your insurer, pharmacist and the official TrumpRx.gov site for the latest, authoritative details.